Jason Douglas Wilson, Chief Financial Officer at REATA PHARMACEUTICALS INC (RETA), sold 3,900 shares at $73.11 ($283K) on 2019-08-15, disclosed to the SEC on 2019-08-16.
Open-market sale of $283k RETA by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $72.25 | 2,128 | $154K | 54.3% |
| 2 | $73.11 | 1,772 | $130K | 45.7% |
| Total | $72.64 avg | 3,900 | $283K | 100% |
| Filing → |
| RETA | SELL | 2019-10-21 | $1.7M | — | Filing → |
| RETA | SELL | 2019-10-15 | $5.5M | — | Filing → |
| RETA | SELL | 2019-10-15 | $2.1M | — | Filing → |